Wednesday, October 28, 2026
Data from SEC filings, checked daily
Public filings, plainly told
WallStPal · PDF guide
QURE Insider Trading: uniQure N.V. Insider Buys and Sells · https://wallstpal.com/stock/qure/insider-trading/ · saved 2026-10-28

About this page

Insider trades reported on SEC Form 4: when the people who run a company buy or sell its shares with their own money.

How to read it

Form 4
The form a company insider (officer, director or owner of more than 10%) must file with the SEC within two business days of buying or selling the company's shares.
Buy (P) and Sell (S)
Open-market purchases and sales. Gifts, option exercises and automatic tax withholding are left out because they say little about what the insider thinks.
Value
Shares times price, as reported on the filing.
10b5-1
A trade made under a plan set up in advance. Planned sales are common and usually say less than an unplanned purchase.
Late filing
A Form 4 filed more than two business days after the trade.
Vs. S&P 500
How the stock did after the trade minus how the overall market did in the same weeks.

A real example

In January 2016, when bank stocks were falling, JPMorgan Chase CEO Jamie Dimon bought 500,000 JPMorgan shares with his own money, worth about $26 million. His Form 4 made the purchase public within days, and investors read it as a strong sign of confidence.

Explain it like I'm 13

If the coach of a team bets his own allowance that his team will win, that tells you something. A Form 4 is the note a company boss must hand in whenever he buys or sells his own company's shares, so everyone can see it.

Data from public SEC filings and congressional reports. Information, not investment advice. Check every number against the filing linked on the page.

Summarize with AIChatGPTClaudePerplexityGoogle AIGrokCopilot
Insider tradingForm 4

uniQure N.V. (QURE) Insider Trading

12 open-market trades reported since Jun 17, 2026: 0 purchases worth $0 and 12 sales worth $15.7M.

By insider

InsiderRoleBuysBoughtSellsSoldLatest
Matthew C. KapustaCEO0$05$12.1MJul 7, 2026
Walid Abi-SaabChief Medical Officer0$02$1.46MJul 2, 2026
Jack KayeDirector0$02$1.21MJul 2, 2026
Madhavan BalachandranDirector0$02$805KJun 22, 2026
Jeannette PottsGeneral Counsel0$01$145KJun 17, 2026

All trades

QURE insider trades
FiledTradedInsiderRoleTypeSharesPrice ($)ValueHolding3 mo. afterFiling
Jul 7Jul 2Matthew C. KapustaCEOCEO▼ SELL10b5-121,08245.16$952K−3.9%Form 4 ↗
Jul 2Jun 30Walid Abi-SaabChief Medical OfficerChief Medical Officer▼ SELL10b5-130,00046.42$1.39M−17%Form 4 ↗
Jul 2Jun 30Jack KayeDirectorDirector▼ SELL10b5-121,16746.44$983K−45%Form 4 ↗
Jun 30Jun 26Walid Abi-SaabChief Medical OfficerChief Medical Officer▼ SELL1,43446.86$67K−0.8%Form 4 ↗
Jun 26Jun 25Matthew C. KapustaCEOCEO▼ SELL10b5-128,71650.02$1.44M−5.2%Form 4 ↗
Jun 26Jun 24Matthew C. KapustaCEOCEO▼ SELL10b5-16,69650.00$335K−1.3%Form 4 ↗
Jun 22Jun 17Matthew C. KapustaCEOCEO▼ SELL10b5-1164,42944.32$7.29M−23%Form 4 ↗
Jun 22Jun 18Matthew C. KapustaCEOCEO▼ SELL10b5-141,67150.00$2.08M−7.4%Form 4 ↗
Jun 22Jun 17Madhavan BalachandranDirectorDirector▼ SELL10b5-111,68545.06$526K−21%Form 4 ↗
Jun 22Jun 17Jack KayeDirectorDirector▼ SELL10b5-15,29542.57$225K−17%Form 4 ↗
Jun 17Jun 15Madhavan BalachandranDirectorDirector▼ SELL10b5-110,00027.85$279K−19%Form 4 ↗
Jun 17Jun 15Jeannette PottsGeneral CounselGeneral Counsel▼ SELL5,23727.67$145K−3.8%Form 4 ↗
Source: SEC Form 4 filings, retrieved Oct 28, 2026. How we read filings